Gynecologic Malignancies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with a pathological diagnosis of gynecologic malignancy, including ovarian cancer, cervical cancer, or endometrial cancer, who are undergoing surgery and/or chemo-radiotherapy; 2) Tumor stage III–IV; 3) Age between 14 and 70 years; 4) An estimated survival time of more than 3 months; 5) Awareness of their diagnosis, ability to provide informed consent to participate in this study, and possession of basic verbal communication skills.
Exclusion criteria
Exclusion criteria: 1) Presence of severe chronic diseases, immune system disorders, or other malignancies; 2) Current psychiatric disorders or a documented history of psychiatric illness; 3) Receipt of other psychological interventions, psychotropic medications related to psychological quality, or exercise therapy within the past 3 months; 4) Impairments in mobility, hearing, speech, or cognitive function; 5) Current participation in other clinical studies; 6) Allergy to lavender.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patien Health Questionnaire-9(PHQ-9);Generalized Anxiety Disorder-7 (GAD-7);Pittsburgh Sleep Quality Index (PSQI);Fear of Progression Questionnaire–Short Form (FoP-Q-SF); | — |
Countries
China
Contacts
Women's Hospital, School of Medicine, Zhejiang University